Skip to main content

NEXTBio Capital Management LP

Location
AUSTIN, TX
Portfolio Value
Small $215,369,990
Diversification
Diversified
Filing Date
Global Rank
#4,015 / 8,603 ▲ 677 · as of Mar 2026
Top Industry
Biotechnology 94.8%
3Y Alpha vs SPY
+78.0%
Period ended 3 months ago
Filed May 14, 2026 · 56d
2 quarters · since Dec 2025

Clone Performance

Feb 2026–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+33.7%
SPY
+10.0%
Annualised alpha
+80.6%
Max drawdown
−18.7%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

24 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
14.8%
+1.7 pts
Top 5
48.9%
+2.8 pts
Top 10
71.0%
+1.0 pts
HHI
699
Dec 2025 → Mar 2026 · range 655 – 699
Diversified+44

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 100.0% $215,369,990

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
9 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
7 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
24 positions · $215,369,990 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History